667, L.P., Director at TScan Therapeutics, Inc. (TCRX), bought 1,425,000 shares at $15.00 ($21.4M) on 2021-07-20, disclosed to the SEC on 2021-07-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 104,698 | $1.6M | 7.3% |
| 2 | $15.00 | 1,320,302 | $19.8M | 92.7% |
| Total | $15.00 avg | 1,425,000 | $21.4M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |